 |
市場調査レポート
商品コード
1448396
がん性疼痛の世界市場規模、シェア、成長分析、薬剤別、適応疾患別 - 産業予測2024～2031年Global Cancer Pain Market Size, Share, Growth Analysis, By Drug(Opioids, Morphine), By Disease Indication(Lung Cancer, Colorectal Cancer) - Industry Forecast 2024-2031 |
||||||
| がん性疼痛の世界市場規模、シェア、成長分析、薬剤別、適応疾患別 - 産業予測2024～2031年 |
|
出版日: 2024年03月03日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のがん性疼痛の市場規模は、2022年に65億5,000万米ドルとなり、2023年の69億2,000万米ドルから、2031年までには107億米ドルに成長し、予測期間（2024～2031年）のCAGRは5.6%で成長する見通しです。
世界のがん性疼痛市場が成長しているのは、がんに罹患する人が増えていること、人口が高齢化していること、ヘルスケアにより多くの資金が費やされていること、ヘルスケア企業がより多くの調査を行っていることなどが理由です。例えば、2020年、米国がん協会によると、米国では新たに約180万人ががんに罹患し、約60万6,520人ががんで死亡しました。同年、国際がん研究機関によると、世界では新たに約106万5,960人が大腸がんに罹患しました。加齢が身体に与える影響や遺伝子の変化のため、高齢者はがんになりやすいです。国立がん研究所によれば、乳がんの平均診断年齢は61歳、大腸がんは68歳、肺がんは70歳、前立腺がんは66歳です。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
がん性疼痛の世界市場：薬剤別
- 市場概要
- オピオイド
- モルヒネ
- フェンタニル
- 非オピオイド
- アセトアミノフェン
- 非ステロイド性抗炎症薬（NSAID）
- 神経遮断薬
- その他
がん性疼痛の世界市場：適応疾患別
- 市場概要
- 肺がん
- 結腸直腸がん
- 乳がん
- 前立腺がん
- 血液がん
- その他
がん性疼痛の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Pfizer（USA）
- Johnson & Johnson（USA）
- Purdue Pharma（USA）
- Novartis（Switzerland）
- Heron Therapeutics（USA）
- Teva Pharmaceutical Industries（Israel）
- Eli Lilly and Company（USA）
- AstraZeneca（UK）
- GlaxoSmithKline（UK）
- Merck & Co., Inc.（USA）
Global Cancer Pain Market size was valued at USD 6.55 billion in 2022 and is poised to grow from USD 6.92 billion in 2023 to USD 10.70 billion by 2031, growing at a CAGR of 5.6% in the forecast period (2024-2031).
The global cancer pain market is growing because there are more people getting cancer, the population is getting older, more money is being spent on healthcare, and healthcare companies are doing more research. For example, in 2020, the American Cancer Society said there were about 1.8 million new cases of cancer and around 606,520 people died from cancer in the U.S. That same year, there were about 1,065,960 new cases of colorectal cancer worldwide, according to the International Agency for Research on Cancer. Older people are more likely to get cancer because of how aging affects the body and changes in genes. The National Cancer Institute says the average age for diagnosing breast cancer is 61, colorectal cancer is 68, lung cancer is 70, and prostate cancer is 66.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cancer Pain Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cancer Pain Market Segmental Analysis
The global cancer pain market is segmented on the basis of drug type, disease indication, region. By drug type, the market is segmented into opioids, morphine, fentanyl, others, non-opioids, acetaminophen, non-steroidal anti-inflammatory drugs (nsaids), nerve blockers. By disease indication, the market is segmented into lung cancer, colorectal cancer, breast cancer, prostate cancer, blood cancer, others. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.
Drivers of the Global Cancer Pain Market
New ways of managing pain, better ways to give medicine, and treatments made just for each person are making cancer pain management work better and be easier to get to.
Restraints in the Global Cancer Pain Market
The possibility of getting used to a drug, needing it more, and having side effects from pain medicines can stop the market from growing.
Market Trends of the Global Cancer Pain Market
More attention is being put on treating each person differently based on their genes and molecules, which is changing how cancer pain is managed.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Cancer Pain Market by Drug
- Market Overview
- Opioids
- Morphine
- Fentanyl
- Others
- Non-opioids
- Acetaminophen
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Nerve Blockers
Global Cancer Pain Market by Disease Indication
- Market Overview
- Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Blood Cancer
- Others
Global Cancer Pain Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Pfizer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Purdue Pharma (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Heron Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. (USA0
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
